University of Chicago Medicine Comprehensive Cancer Center’s Post

The CIRCULATE Phase II/II trial will evaluate what kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA after surgery for colon cancer. https://lnkd.in/gHgEfMsn